Lower-face assessment
The clinic reviews whether reduced jawline definition is primarily related to tissue laxity or another cause.
555-555-5555
mymail@mailservice.com
Explore consultation-led Ultherapy jawline lifting in Seoul at LOUAVE Dermatology Clinic. Treatment planning considers lower-face laxity, jawline continuity, the under-chin area, facial proportions and real-time ultrasound imaging.
A softened jawline can be influenced by skin laxity, localised fullness, muscle size, bone structure or several factors together. Ultherapy is selected only when the assessed concern is suitable for ultrasound lifting.
Ultherapy PRIME
Lower face & jawline
Cleansing & numbing
Individually mapped
Ultherapy PRIME at LOUAVE
Ultherapy uses focused ultrasound energy as part of a non-surgical lifting approach. For jawline treatment, selected lower-face, mandibular-border and under-chin zones may be considered in relation to one another.
LOUAVE presents Ultherapy PRIME as its current platform. Ultrasound imaging supports review of tissue layers and helps the practitioner select appropriate treatment depths, directions and coverage.
The clinic reviews whether reduced jawline definition is primarily related to tissue laxity or another cause.
Ultrasound visualisation helps identify tissue layers and supports anatomy-led treatment placement.
Changes generally develop gradually rather than producing an immediate surgical-style result.
Ultherapy may be considered for selected laxity concerns. Fat distribution, muscle size, skin quality and skeletal structure may require different or combined approaches.
Treatment may be discussed when mild or moderate skin laxity has reduced definition along the mandibular border.
Selected lower-face mapping may be considered when tissue descent begins to interrupt the jawline outline.
The under-chin area may be assessed together with the jawline when loose skin affects lower-face definition.
Laxity in the lower cheek may influence the jawline and may be included in the broader treatment map.
Treatment planning may consider how the jawline connects visually with the under-chin and upper-neck areas.
Some patients discuss treatment before lower-face laxity becomes more advanced or structurally complex.
Skin laxity, localised fat, masseter muscle size, chin projection, bone structure and posture can all influence the lower-face outline. The primary cause should be identified before treatment is selected.
The location and degree of tissue laxity are reviewed before treatment depth and coverage are planned.
Primary Ultherapy concernFullness caused mainly by localised fat may require a contouring approach rather than lifting alone.
Cause must be identifiedA wide lower face caused by prominent masseter muscles may be discussed separately from skin-lifting treatment.
Alternative treatment possibleChin shape and projection influence the side profile and may affect how jawline definition is perceived.
Structural assessmentExisting side-to-side differences are reviewed before an individualised treatment pattern is designed.
Individual mappingFillers, threads, Botox, surgery and previous energy treatments should be disclosed during consultation.
Treatment history requiredThis sequence adapts LOUAVE’s general Ultherapy PRIME process. Exact preparation, treatment time and treatment coverage vary according to the individual plan.
Lower-face laxity, jawline shape, under-chin fullness, previous procedures and expectations are reviewed.
The treatment area is cleansed and topical numbing cream may be applied to support comfort.
Ultrasound gel is applied and selected jawline, lower-face and under-chin zones are mapped.
Tissue layers are visualised while ultrasound energy is delivered to the selected treatment areas.
The treated areas are reviewed and suitable calming or recovery-focused care may be provided.
Result timing, tenderness, swelling and visible definition vary between patients. The sequence below is general guidance, not a guaranteed outcome schedule.
Temporary redness, warmth, tenderness, swelling or tingling may occur along the treated lower-face area.
Many patients resume normal activities relatively quickly, although sensitivity may persist for some individuals.
Gradual firmness or definition changes may become more noticeable from around one month after treatment.
Collagen-related changes may continue developing over the following months according to individual response.
Share your arrival, departure and important-event dates with the clinic. Allow sufficient time for consultation, treatment and possible temporary tenderness or swelling before photography, events or international travel.
Photographs may support an initial discussion, but the underlying cause of reduced jawline definition and final treatment suitability require individual assessment.
Ultherapy targets selected laxity concerns. Thermage FLX, Titanium, ONDA or injectable treatment may be discussed when the treatment priority is different.
Head angle, chin position, posture, expression, lighting, camera distance and the time between photographs can significantly influence how jawline definition appears. Individual treatment outcomes vary.
These answers provide general guidance. Treatment details should be confirmed by LOUAVE after individual assessment.
The suitable approach depends on whether the concern relates mainly to laxity, skin firmness, localised fullness or muscle size.
Explore focused ultrasound planning for selected facial lifting and lower-face support concerns.
Explore Treatment →Review focused ultrasound information for selected under-chin laxity and definition concerns.
Explore Treatment →Explore radiofrequency tightening information for selected jawline firmness and skin-quality concerns.
Explore Treatment →Review Botox information when prominent masseter muscles contribute to lower-face width.
Explore Treatment →Share your lower-face concerns, previous fillers, Botox, threads or lifting treatments, preferred appointment dates and travel schedule. Final suitability and treatment details are confirmed after individual assessment.
This page provides general educational information and does not replace an individual medical consultation. Treatment suitability, approved treatment zones, imaging findings, treatment depth, number of treatment lines, energy settings, discomfort, possible side effects, recovery, result timing and duration vary between individuals. Temporary redness, swelling, tenderness, pain, tingling, sensitivity, welting or transient nerve-related effects may occur. Patients should disclose medical conditions, implanted devices, pregnancy or breastfeeding status, medications and previous Botox, fillers, threads, surgery or energy-based procedures. Ultherapy does not change skeletal structure, remove substantial amounts of fat or reproduce surgical lower-face-lift results. Results cannot be guaranteed, and the final treatment plan must be confirmed after individual assessment.